Brandon Pham

Also affiliated with Horizon Therapeutics (United States), Smith-Kettlewell Eye Research Institute, Stanford University

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “GRHL3 activates FSCN1 to relax cell-cell adhesions between migrating keratinocytes during wound reepithelialization”.

GRHL3 activates FSCN1 to relax cell-cell adhesions between migrating keratinocytes during wound reepithelialization

JCI Insight(2021)10.1172/jci.insight.142577

N/A

0DataRank · unranked

31 citations

Sanan Venkatesh, Samuel Refuerzo, Brandon Pham, A Bayat, Rachel Herndon Klein +6 more

Hearing Dysfunction After Treatment With Teprotumumab for Thyroid Eye Disease

American Journal of Ophthalmology(2022)10.1016/j.ajo.2022.02.015

N/A

0DataRank · unranked

83 citations

Amee D. Azad, Linus Amarikwa, Brandon Pham, Clara J. Men, Daniel N. Kaplan +8 more

Teprotumumab for the Treatment of Recalcitrant Thyroid Eye Disease

Ophthalmic Plastic and Reconstructive Surgery(2023)10.1097/iop.0000000000002564

N/A

0DataRank · unranked

18 citations

Linus Amarikwa, Brandon Pham, Connie M. Sears, Kevin D. Clauss, Bradford W. Lee +9 more

Reply

Retina(2024)10.1097/iae.0000000000004134

N/A

0DataRank · unranked

0 citations

Irmak Karaca, Brandon Pham, Amir Akhavanrezayat, Günay Uludağ, Çigdem Yaşar +9 more